作者

Dr Paul England

高级专业支持律师

Read More

Matthew Royle, Ph.D.

合伙人

Read More

Louisa Penny

高级法律顾问

Read More

Amanda Ebbutt

合伙人

Read More
作者

Dr Paul England

高级专业支持律师

Read More

Matthew Royle, Ph.D.

合伙人

Read More

Louisa Penny

高级法律顾问

Read More

Amanda Ebbutt

合伙人

Read More

2018年4月25日

Synapse - law for life sciences - April 2018

This month on Synapse

European Commission's 8th Report on the monitoring of patent settlements

Amanda Ebbutt and Louisa Penny report the findings of the European Commission's 8th Report on the monitoring of patent settlements in the pharmaceutical sector.

Topical issues

Bolar and the experimental use exemptions in the UK

Paul England explains how there are three exemptions in the UK that potentially apply to patent infringement by life sciences products.

General Court considers requirements for designation as an orphan medicinal product

Belinda Lavin considers a recent General Court decision concerning the requirements for designation of a medicinal product as an orphan medicinal product.

Brexit and the life sciences: April 2018 update

Matthew Royle and Paul England discuss the impact that the draft Brexit withdrawal and transition arrangements have on life sciences products.

The UPC and Unitary Patent: April 2018 update

Sara Burghart and Paul England discuss the latest status in the UK and Germany of the ratification of the Unified Patent Court and Unitary Patent.


Visit Synapse


Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

英国脱欧

Brexit – what's the deal for business?

2021年1月12日
Briefing

作者

点击此处了解更多
capsules in petri dish

Court of Appeal Judgment confirms that Pfizer and Flynn should not yet be fined for excessive pricing of anti-epilepsy drug

2020年3月12日
QUICK READ

作者 Paolo Palmigiano 以及 Louisa Penny

点击此处了解更多